tuberculosis-immune reconstitution inflammatory syndrome

2
459 Picture. doi: 10.2169/internalmedicine.3580-19 Intern Med 59: 459-460, 2020 http://internmed.jp PICTURES IN CLINICAL MEDICINE Tuberculosis-immune Reconstitution Inflammatory Syndrome Satoshi Hamada 1,2 and Yoshihiko Adachi 3 Key words: immune reconstitution inflammatory syndrome, spondylitis, tuberculosis (Intern Med 59: 459-460, 2020) (DOI: 10.2169/internalmedicine.3580-19) An 87-year-old woman with hypertension and hyperlipi- demia complained of dyspnea and a fever. Computed to- mography (CT) revealed a left-sided pleural effusion, reveal- ing a lymphocytic exudate with 74.3 IU/L of adenosine deaminase, and spondylodiscitis in the Th6 segment (Pic- ture A, B). Sputum culture revealed Mycobacterium tubercu- losis without drug resistance. We started antituberculosis therapy with isoniazid (200 mg/day), rifampin (450 mg/day), and ethambutol (750 mg/day) with good adherence. Her fe- ver recurred two weeks following antituberculosis therapy initiation. One month later, CT revealed a new mass in the right upper lobe that was positive on tuberculosis- polymerase chain reaction (assessed using CT-guided bi- opsy) and progressive spondylodiscitis (Picture C, D). Five months later, CT showed that the mass in the right upper lobe had shrunk in size with progressive spondylodiscitis (Picture E, F). We diagnosed this clinical course as tuberculosis-immune reconstitution inflammatory syndrome (IRIS). Tuberculosis-IRIS is not a rare phenomenon; how- ever, it can be misdiagnosed as superimposed infections, treatment failure, or tuberculosis relapse (1). The authors state that they have no Conflict of Interest (COI). Department of Respiratory Medicine, Ayabe City Hospital, Japan, Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Japan and Department of Cardiovascular Medicine, Ayabe City Hospital, Japan Received: June 27, 2019; Accepted: August 26, 2019; Advance Publication by J-STAGE: October 7, 2019 Correspondence to Dr. Satoshi Hamada, [email protected]

Upload: others

Post on 24-Mar-2022

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Tuberculosis-immune Reconstitution Inflammatory Syndrome

459

Picture.

doi: 10.2169/internalmedicine.3580-19

Intern Med 59: 459-460, 2020

http://internmed.jp

【 PICTURES IN CLINICAL MEDICINE 】

Tuberculosis-immune ReconstitutionInflammatory Syndrome

Satoshi Hamada 1,2 and Yoshihiko Adachi 3

Key words: immune reconstitution inflammatory syndrome, spondylitis, tuberculosis

(Intern Med 59: 459-460, 2020)(DOI: 10.2169/internalmedicine.3580-19)

An 87-year-old woman with hypertension and hyperlipi-

demia complained of dyspnea and a fever. Computed to-

mography (CT) revealed a left-sided pleural effusion, reveal-

ing a lymphocytic exudate with 74.3 IU/L of adenosine

deaminase, and spondylodiscitis in the Th6 segment (Pic-

ture A, B). Sputum culture revealed Mycobacterium tubercu-losis without drug resistance. We started antituberculosis

therapy with isoniazid (200 mg/day), rifampin (450 mg/day),

and ethambutol (750 mg/day) with good adherence. Her fe-

ver recurred two weeks following antituberculosis therapy

initiation. One month later, CT revealed a new mass in the

right upper lobe that was positive on tuberculosis-

polymerase chain reaction (assessed using CT-guided bi-

opsy) and progressive spondylodiscitis (Picture C, D). Five

months later, CT showed that the mass in the right upper

lobe had shrunk in size with progressive spondylodiscitis

(Picture E, F). We diagnosed this clinical course as

tuberculosis-immune reconstitution inflammatory syndrome

(IRIS). Tuberculosis-IRIS is not a rare phenomenon; how-

ever, it can be misdiagnosed as superimposed infections,

treatment failure, or tuberculosis relapse (1).

The authors state that they have no Conflict of Interest (COI).

1Department of Respiratory Medicine, Ayabe City Hospital, Japan, 2Department of Advanced Medicine for Respiratory Failure, Graduate School

of Medicine, Kyoto University, Japan and 3Department of Cardiovascular Medicine, Ayabe City Hospital, Japan

Received: June 27, 2019; Accepted: August 26, 2019; Advance Publication by J-STAGE: October 7, 2019

Correspondence to Dr. Satoshi Hamada, [email protected]

Page 2: Tuberculosis-immune Reconstitution Inflammatory Syndrome

Intern Med 59: 459-460, 2020 DOI: 10.2169/internalmedicine.3580-19

460

Reference

1. Cheng VC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxi-

cal deterioration during antituberculosis therapy in non-HIV-

infected patients. Eur J Clin Microbiol Infect Dis 21: 803-809,

2002.

The Internal Medicine is an Open Access journal distributed under the Creative

Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To

view the details of this license, please visit (https://creativecommons.org/licenses/

by-nc-nd/4.0/).

Ⓒ 2020 The Japanese Society of Internal Medicine

Intern Med 59: 459-460, 2020